Couverture de The IP Driven Start-up

The IP Driven Start-up

The IP Driven Start-up

De : Marks & Clerk
Écouter gratuitement

À propos de ce contenu audio

 Essential topics for the rising stars of the start-up community Direction Economie Management et direction
Épisodes
  • Episode 3: Why deep-tech ventures can fail - and the framework that explains it

    Episode 3: Why deep-tech ventures can fail - and the framework that explains it
    Mar 10 2026
    In this episode, Marks & Clerk's Anis Naidu is joined by Dr. Uday Phadke and Sam Dods, co-founders of Triple Chasm. Drawing on research across 7,000 companies globally, Uday and Sam have built a rigorous, data-driven framework for understanding why so many technology ventures fail to make the journey from laboratory to commercial success - and what the successful ten per cent consistently do differently.
    Afficher plus Afficher moins
    30 min
  • Episode 2: What investors really look for — and the IP mistakes that can cost start-ups their chance

    Episode 2: What investors really look for — and the IP mistakes that can cost start-ups their chance
    Mar 10 2026
    In this episode, Marks & Clerk's Anis Naidu is joined by two of the North West's most experienced voices in early-stage investment and innovation: Dr. Andy Round, Senior Investment Director at Deepbridge Capital, and Andy Roberts, former Head of Innovation at Bruntwood SciTech. Between them, they bring decades of experience backing, advising and accelerating life science start-ups.
    Afficher plus Afficher moins
    25 min
  • Episode 1: From lab to market - the real story of commercialising university research

    Episode 1: From lab to market - the real story of commercialising university research
    Mar 10 2026
    In this episode, Marks & Clerk's Anis Naidu sits down with Professor Aline Miller, Associate Vice President for Enterprise at the University of Manchester and founder of Manchester BIOGEL, which raised over £4 million, built a global distribution network, and achieved a successful exit in 2023. Now developing her second venture, Molla Pharm, Aline offers a thoughtful reflection on a decade of commercialising university research, speaking with the clarity and candour that come from firsthand experience.
    Afficher plus Afficher moins
    32 min
adbl_web_anon_alc_button_suppression_c
Aucun commentaire pour le moment